Therefore, adenovirus and AAV-mediated gene transduction of IGF2BP2, or the construction of transgenic mice that stably express IGF2BP2 in hepatocytes, might be a novel way to construct a NASH model. Here, IGF2BP2 is linked to metabolic dysfunction-associated steatohepatitis.